期刊文献+

急性脑梗死患者经重组组织型纤溶酶原激活物静脉溶栓治疗后预后的影响因素研究 被引量:20

Influencing Factors of Prognosis in Acute Cerebral Infarction Patients Treated by Intravenous Thrombolysis of rt-PA
下载PDF
导出
摘要 目的探讨急性脑梗死患者经重组组织型纤溶酶原激活物(rt-PA)静脉溶栓治疗后预后的影响因素。方法选取2014年10月—2017年10月在无锡市锡山人民医院接受rt-PA静脉溶栓治疗的急性脑梗死患者110例,根据改良Rankin量表(mRS)评分分为预后良好组62例和预后不良组48例。比较两组患者性别、年龄、糖尿病病史、高血压病史、吸烟史、饮酒史、颅内动脉狭窄及心房颤动发生情况、入院时美国国立卫生研究院卒中量表(NIHSS)评分、发病至溶栓启动时间,急性脑梗死患者经rt-PA静脉溶栓治疗后预后的影响因素分析采用多因素Logistic回归分析。结果两组患者性别,有高血压病史、吸烟史、饮酒史者所占比例比较,差异无统计学意义(P>0.05);预后良好组患者年龄≥75岁者所占比例、有糖尿病病史者所占比例、入院时NIHSS评分、颅内动脉狭窄发生率、心房颤动发生率均低于预后不良组,发病至溶栓启动时间短于预后不良组(P<0.05)。多因素Logistic回归分析结果显示,年龄[OR=10.334,95%CI(2.831,37.719)]、糖尿病病史[OR=6.050,95%CI(1.615,22.177)]、心房颤动[OR=8.392,95%CI(1.661,42.385)]、入院时NIHSS评分[OR=6.781,95%CI(1.898,24.233)]、发病至溶栓启动时间[OR=9.137,95%CI(2.462,33.908)]是急性脑梗死患者经rt-PA静脉溶栓治疗后预后的影响因素(P<0.05)。结论高龄、糖尿病病史、入院时NIHSS评分高、心房颤动、发病至溶栓启动时间延长是急性脑梗死患者经rt-PA静脉溶栓治后预后不良的影响因素,应根据以上影响因素积极采取有效的干预措施以改善患者预后。 Objective To investigate the influencing factors of prognosis in acute cerebral infarction patients treated by intravenous thrombolysis of rt-PA.Methods A total of 110 acute cerebral infarction patients treated by intravenous thrombolysis of rt-PA were selected in Xishan People's Hospital of Wuxi from October 2014 to October 2017,and they were divided into A group(with good prognosis,n=62)and B group(with poor prognosis,n=48)according to the modified Rankin Scale score.Gender,age,history of diabetes,hypertension,smoking and drinking,incidence of intracranial arterial stenosis and atrial fibrillation,NIHSS score at admission,duration between attack and intravenous thrombolysis were compared the two groups,and multivariate Logistic regression analysis was used to analyze the influencing factors of prognosis in acute cerebral infarction patients treated by intravenous thrombolysis of rt-PA.Results No statistically significant differences of gender or proportion of patients with history of hypertension,smoking or drinking was found between the two groups(P>0.05);proportion of patients with age equal or over 75 years old,proportion of patients with diabetes history,incidence of intracranial arterial stenosis and atrial fibrillation,NIHSS score at admission in A group were statistically significantly lower than those in B group,and duration between attack and intravenous thrombolysis in A group was statistically significantly shorter than that in B group(P<0.05).Multivariate Logistic regression analysis results showed that,age〔OR=10.334,95%CI(2.831,37.719)〕,diabetes history〔OR=6.050,95%CI(1.615,22.177)〕,atrial fibrillation〔OR=8.392,95%CI(1.661,42.385)〕,NIHSS score at admission〔OR=6.781,95%CI(1.898,24.233)〕,duration between attack and intravenous thrombolysis〔OR=9.137,95%CI(2.462,33.908)〕were influencing factors of prognosis in acute cerebral infarction patients treated by intravenous thrombolysis of rt-PA(P<0.05).Conclusion Advanced age,diabetes history,high NIHSS score at admission,atrial fibrillation and extension of between attack and intravenous thrombolysis are influencing factors of poor prognosis in acute cerebral infarction patients treated by intravenous thrombolysis,so we should adopt active and effective intervention measures according above influencing factors to improve the prognosis.
作者 韩杨 周其达 秦琳 潘晓帆 朱晓华 周燕 奚广军 HAN Yang;ZHOU Qi-da;QIN Lin;PAN Xiao-fan;ZHU Xiao-hua;ZHOU Yan;XI Guang-jun(Department of Neurology,Wuxi Branch of Zhongda Hospital Affiliated to Southeast University(Xishan People's Hospitalof Wuxi),Wuxi 214105,China;Department of Neurology,Wuxi People's Hospital Affiliated to Nanjing Medical University,Wuxi 214023,China)
出处 《实用心脑肺血管病杂志》 2018年第11期42-45,共4页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
基金 国家自然科学基金青年基金(81201051)
关键词 脑梗死 重组组织型纤溶酶原激活物 静脉溶栓 影响因素分析 Cerebral infarction Recombinant tissue plasminogen activator Intravenous thrombolysis Root causeanalysis
  • 相关文献

参考文献16

二级参考文献104

  • 1丁宏岩,董强.基底动脉梗死的治疗:动脉和静脉溶栓效果比较的系统分析[J].中国卒中杂志,2006,1(6):414-416. 被引量:126
  • 2贺茂林.老年脑梗死溶栓治疗值得注意的问题[J].中华老年多器官疾病杂志,2004,3(4):246-248. 被引量:7
  • 3王伊龙.临床应用重组组织型纤溶酶原激活剂静脉溶栓治疗缺血性卒中专家共识[J].中华内科杂志,2006,45(7):613-614. 被引量:52
  • 4中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5221
  • 5The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ische- mic stroke[J]. N Engl J Med, 1995,333(24) :1581-1587.
  • 6Haeke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4. 5 hours after acute ischemie stroke [ J ]. N Engl J Med, 2008,359 ( 13 ) : 1317-1329.
  • 7Adams HPJr, del ZG, Alberts M J, et al. Guidelines for the early management of adults with ischemic stroke : a guideline from the A- merican Heart Association /American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascu- lar Disease and Quality of Care Outcomes in Research Interdiscipli- nary Working Groups:the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists [J]. Stroke, 2007,38(4) :1655-1711.
  • 8Zinkstok SM, Roos YB. Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial [ J ]. Lancet, 2012,380 ( 8 ) :731-737.
  • 9Tanne D, Macko RF, Lin Y, Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute is- chemic stroke [ J ]. Stroke, 2006,37 (7) : 1798-804.
  • 10Chen B, Cheng Q, Yang K, et al. Thrombin mediates severe neu- rovascular injury during isehemia [ J ]. Stroke, 2010,41 ( 10 ) : 2348-2352.

共引文献33490

同被引文献195

引证文献20

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部